Overview
Health and Quality of Life Outcomes, published by BioMed Central (United Kingdom), published 833 papers in 2021–2025, and these papers have received 12,781 citations so far. Its h-index is 183 and its two-year mean citedness is 3.24. On the ITS Journal Score it ranks #2,687 of 62,158 ranked journals and #513 of 8,758 in Medicine.
Key figures
Citations are those received so far by the papers published in these years, so the most recent years have had less time to collect them. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor. Citation impact trend compares how often a journal's 2024-25 papers are cited with how often its 2021-22 papers were cited, each measured against all ranked journals' papers of the same years, so newer papers are not at a disadvantage. "Not enough papers" or "Not enough data" means fewer than 50 papers in one of the two-year periods (or fewer than 50 citations to the earlier papers). Values above +300% or below -90% are shown as "+300% or more" or "-90% or less": such extreme values come from very low citation counts for the earlier papers.
Papers and citations by year
| Year | Papers | Citations so far to that year's papers | Open-access papers |
|---|---|---|---|
| 2020 | 376 | 13,239 | 376 |
| 2021 | 273 | 6,801 | 273 |
| 2022 | 171 | 3,036 | 171 |
| 2023 | 135 | 1,671 | 135 |
| 2024 | 113 | 848 | 113 |
| 2025 | 141 | 425 | 141 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Quality of Life Research | Economics, Econometrics and Finance | 81.7 | 1,390 | 66% |
| PharmacoEconomics | Economics, Econometrics and Finance | 77.9 | 580 | 78% |
| International Journal of Technology Assessment in Health Care | Economics, Econometrics and Finance | 65.0 | 1,630 | 96% |
| Journal of Cancer Survivorship | Medicine | 76.0 | 980 | 68% |
| Expert Review of Pharmacoeconomics & Outcomes Research | Economics, Econometrics and Finance | 69.4 | 582 | 45% |
| PharmacoEconomics - Open | Economics, Econometrics and Finance | 67.9 | 380 | 100% |
| Journal of Patient-Reported Outcomes | Medicine | 69.3 | 711 | 100% |
| Value in Health | Economics, Econometrics and Finance | 64.4 | 21,155 | 49% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 1477-7525
- Print ISSN: 1477-7525
- Publisher: BioMed Central
- Listed in DOAJ: Yes (checked against DOAJ)
- Crossref: ISSN found in Crossref
- OpenAlex: S77368557
- Journal website: link.springer.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Health and Quality of Life Outcomes?
It is 78.5 out of 100, which places it #2,687 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Health and Quality of Life Outcomes?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 3.24.
Is Health and Quality of Life Outcomes open access?
100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.
Does Health and Quality of Life Outcomes charge a publication fee?
DOAJ records an article processing charge of 2,890 EUR. Check the journal's website for the current fee and any waivers.